Abstract
Introduction
Globally, a metabolic disorder like Diabetes is considered as one of the largest global health issues, as it accounts for the majority of the disease burden and happens to be one of the leading causes of mortality as well as reduced life expectancy across the world. As in 2019, India is home to the second-largest number (77 million) of Diabetic adults and the number of people affected has been increasing rapidly over the years. Termed as “the diabetes capital of the world,” with every fifth diabetic in the world being an Indian, there is an urgent need to address many critically significant challenges posed by Diabetes in India, like, increasing prevalence among young people in urban areas, less awareness among people, high cost of disease management, limited healthcare facilities, suboptimal diabetes control etc. In Indian context, not enough attempts have been made to observe and understand the long-term pattern of diabetes incidence and mortality. This study aims to provide deep insights into the recent trends of diabetes incidence and mortality in India from 1990 to 2019.
Materials and methods
This is an observational study based on the most recent data from the Global Burden of Disease (GBD) Study 2019. We extracted numbers, age-specific and age-standardized incidence and mortality rates of diabetes (from 1990 to 2019) from the Global Health Data Exchange. The average annual percentage changes in incidence and mortality were analysed by joinpoint regression analysis; the net age, period, and cohort effects on the incidence and mortality were estimated by age-period-cohort analysis.
Results
During the study period, age-standardized incidence and mortality rates of diabetes in India experienced an upsurge in numbers, the incidence rate increased from 199.14 to 317.02, and consequently, mortality increased from 22.30 to 27.35 per 100,000 population. The joinpoint regression analysis showed that the age-standardized incidence significantly rose by 1.63 % (95 % CI: 1.57 %, 1.69 %) in Indian males and 1.56 % in Indian females (95 % CI: 1.49 %, 1.63 %) from 1990 to 2019. On the other hand, the age-standardized mortality rates rose by 0.77 % (95 % CI: 0.24 %, 1.31 %) in Indian males and 0.57 % (95 % CI: -0.54 %, 1.70 %) in Indian females. For age-specific rates, incidence increased in most age groups, with exception of age groups 5–9, 70–74, 75–79 and 80–84 in male, and age groups 5–9, 75–79 and 80–84 in female. Mortality in male saw a decreasing trend till age group 20–24, whereas in female, the rate decreased till age group 35–39. The age effect on incidence showed no obvious changes with advancing age, but the mortality significantly increased with advancing age; period effect showed that both incidence and mortality increased with advancing time period; cohort effect on diabetes incidence and mortality decreased from earlier birth cohorts to more recent birth cohorts, while incidence showed no material changes from 1975 to 1979 to 2000–2004 birth cohort.
Conclusions
Mortality of diabetes decreased in younger age groups but increased in older age groups; however, Incidence increased in most age groups for both male and female. The net age or period effect showed an unfavourable trend while the net cohort effect presented a favourable trend. Aging was likely to drive a continued increase in the mortality of diabetes. Timely population-level interventions aiming for health education, lifestyle modification with special emphasis on the promotion of physical activity and healthy diet should be conducted, especially for male and earlier birth cohorts at high risk of diabetes.
Similar content being viewed by others
Change history
12 August 2021
A Correction to this paper has been published: https://doi.org/10.1007/s40200-021-00865-5
References
International diabetes federation. IDF diabetes Atlas, D, 9th ed; 2019.
Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, Chia KS, Zimmet PZ. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care. 2016;39(3):472–85.
Norhammar A, Bodegård J, Nyström T, Thuresson M, Eriksson JW, Nathanson D. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013. Diabetologia. 2016;59(8):1692–701.
McAllister DA, Read SH, Kerssens J, Livingstone S, McGurnaghan S, Jhund P, Wild SH. Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus. Circulation. 2018;138(24):2774–86.
Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, Gregg EW. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014;312(12):1218–26.
Carstensen B, Rønn PF, Jørgensen ME. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016. BMJ Open Diabetes Res Care. 2020;8(1):e001071.
Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27(4):269.
Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, Lo WC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants. Lancet. 2016;387(10027):1513–30.
Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110.
Qiao Q. Age–and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care. 2003;26(6):1770–80.
Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Bhansali A. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–96.
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44(9):1094–101.
Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, Jamal A. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract. 2004;66(3):301–7.
Hwang CK, Han PV, Zabetian A, Ali MK, Narayan KV. Rural diabetes prevalence quintuples over twenty-five years in low-and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012;96(3):271–85.
Gutch M, Razi SM, Kumar S, Gupta KK. Diabetes mellitus: trends in northern India. Indian J Endocrinol Metab. 2014;18(5):731.
Kapoor D, Bhardwaj AK, Kumar D, Raina SK. Prevalence of diabetes mellitus and its risk factors among permanently settled tribal individuals in tribal and urban areas in northern state of sub-Himalayan region of India. Int J Chronic Dis. 2014;2014:380597.
Vision Rehabilitation Centre. Diabetes and the eye. Newsletter 12 [document on Internet]. Hyderabad (India): Vision Rehabilitation Centre; 2003.
Joshi SR, Parikh RM. India; the diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55(Y):323.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10:1.
Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380:2063–6.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30925-9.
Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. Available from http://ghdx.healthdata.org/gbd-results-tool. Accessed 30 Jan 2021.
Luo G, Zhang Y, Guo P, Wang L, Huang Y, Li K. Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis. Int J Cancer. 2017;141(7):1333–44.
Wang J, Bai Z, Wang Z, Yu C. Comparison of secular trends in cervical cancer mortality in China and the United States: an age-period-cohort analysis. Int J Environ Res Public Health. 2016;13(11):1148.
Wang L, Yu C, Liu Y, Wang J, Li C, Wang Q, Zhang ZJ. Lung cancer mortality trends in China from 1988 to 2013: new challenges and opportunities for the government. Int J Environ Res Public Health. 2016;13(11):1052.
Yang Y. Social inequalities in happiness in the United States, 1972 to 2004: an age-period-cohort analysis. Am Sociol Rev. 2008;73(2):204–26.
Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983. pp. 311–24.
Robertson C, Gandini S, Boyle P. Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol. 1999;52(6):569–83.
Mbulaiteye SM, Anderson WF, Ferlay J, Bhatia K, Chang C, Rosenberg PS, Parkin DM. Pediatric, elderly, and emerging adult-onset peaks in Burkitt’s lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol. 2012;87(6):573–8.
Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst. 2008;100(24):1804–14.
Pastor-Barriuso R, López-Abente G. Changes in period and cohort effects on haematological cancer mortality in Spain, 1952–2006. BMC Cancer. 2014;14(1):250.
Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Sherman ME. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol. 2013;31(17):2146.
Jemal A, Ma J, Rosenberg PS, Siegel R, Anderson WF. Increasing lung cancer death rates among young women in southern and midwestern States. J Clin Oncol. 2012;30(22):2739.
Wang Z, Hu S, Sang S, Luo L, Yu C. Age–period–cohort analysis of stroke mortality in China: data from the Global Burden of Disease Study 2013. Stroke. 2017;48(2):271–5.
Rosenberg PS, Check DP, Anderson WF. A web tool for age–period–cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Prev Biomark. 2014;23(11):2296–302.
Wu J, Lin Z, Liu Z, He H, Bai L, Lyu J (2020) Secular trends in the incidence of eating disorders in China from 1990 to 2017: a joinpoint and age–period–cohort analysis. Psychol Med;1–11. https://doi.org/10.1017/S0033291720002706.
Mason KO, Mason WM, Winsborough HH, Poole WK. Some methodological issues in cohort analysis of archival data. Am Sociol Rev. 1973;38(2):242–58.
Yang Y, Land KC. Age-period-cohort analysis: new models, methods, and empirical applications. Abingdon: Taylor & Francis; 2013.
Yang Y, Fu WJ, Land KC. A methodological comparison of age-period-cohort models: the intrinsic estimator and conventional generalized linear models. Sociol Methodol. 2004;34(1):75–110.
Bell A. Age period cohort analysis: a review of what we should and shouldn’t do. Ann Hum Biol. 2020;47(2):208–17.
Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Pal A, Saran R. Prevalence and risk factors of Diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India. Diabetol MetabSyndr. 2017;9(1):8.
Barik A, Mazumdar S, Chowdhury A, Rai RK. Physiological and behavioral risk factors of type 2 diabetes mellitus in rural India. BMJ Open Diabetes Res Care. 2016;4(1):e000255.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research–INdiaDIABetes (ICMR–INDIAB) study. Diabetologia. 2011;54(12):3022–7.
Meshram II, Rao MVV, Rao VS, Laxmaiah A, Polasa K. Regional variation in the prevalence of overweight/obesity, hypertension and diabetes and their correlates among the adult rural population in India. Br J Nutr. 2016;115(7):1265–72.
Walker JD, Slater M, Jones CR, Shah BR, Frymire E, Khan S, Green ME. Diabetes prevalence, incidence and mortality in First Nations and other people in Ontario, 1995–2014: a population-based study using linked administrative data. CMAJ. 2020;192(6):E128-35.
Pal K, Horsfall L, Sharma M, Nazareth I, Petersen I. Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009–2018: a retrospective cohort study. BMJ Open Diabetes Res Care. 2021;9(1):e001989.
Little M, Humphries S, Patel K, Dodd W, Dewey C. Factors associated with glucose tolerance, pre-diabetes, and type 2 diabetes in a rural community of south India: a cross-sectional study. DiabetolMetab Syndr. 2016;8(1):21.
Magliano DJ, Islam RM, Barr EL, Gregg EW, Pavkov ME, Harding JL, Shaw JE. Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019;366:l5003.
Magliano DJ, Chen L, Pavkov ME, Gregg EW, Shaw JE. Trends in diabetes incidence worldwide: are the findings real? Maturitas. 2020;137:63–4.
Schmidt C, Reitzle L, Heidemann C, Paprott R, Ziese T, Scheidt-Nave C, Baumert J. Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013–2014. BMJ Open. 2021;11(1):e041508.
Chi MJ, Liang CK, Lee WJ, Peng LN, Chou MY, Chen LK. Association of new-onset diabetes mellitus in older people and mortality in Taiwan: a 10-year nationwide population-based study. J Nutr Health Aging. 2017;21(2):227–32.
Cobo A, Vázquez LA, Reviriego J, Rodríguez-Mañas L. Impact of frailty in older patients with diabetes mellitus: an overview. Endocrinol Nutr (Engl Ed). 2016;63(6):291–303.
Zhang ZJ, Zhao G, Song Y. Attention is needed for women in the control of diabetic complications in China. Acta Diabetol. 2014;51(6):1081.
Chentli F, Azzoug S, Mahgoun S. Diabetes mellitus in elderly. Indian J Endocrinol Metab. 2015;19(6):744.
Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care. 2003;26(4):1022–5.
Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children–an emerging problem. Diabet Med. 2000;17(12):867–71.
Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, Thankappan KR, et al. Urban rural differences in prevalence of self-reported diabetes in India—The WHO–ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract. 2008;80(1):159–68.
Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care. 2008;31(5):893–8.
Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract. 1999;44(3):207–13.
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.
Liu X, Yu C, Wang Y, Bi Y, Liu Y, Zhang ZJ. Trends in the incidence and mortality of diabetes in China from 1990 to 2017: a joinpoint and age-period-cohort analysis. Int J Environ Res Public Health. 2019;16(1):158.
Decode-Decoda Study Group, & European Diabetes Epidemiology Group. Age, body mass index and type 2 diabetes—associations modified by ethnicity. Diabetologia. 2003;46(8):1063–70.
Cohen AK, Syme SL. Education: a missed opportunity for public health intervention. Am J Public Health. 2013;103(6):997–1001.
Debiasi E. Age-period-cohort analysis: a summary of analytical approaches and results. Centre for Economic Demography and Department of Economic History, Lund University; 2018.
Author information
Authors and Affiliations
Contributions
RPJ, DD and MS contributed in conceptualizing the study. RPJ, NS, PP, DD, KB and MS were responsible for the analysis. All authors contributed to the interpretation of the data, and critically revised all versions of the manuscript and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The references have been updated
Rights and permissions
About this article
Cite this article
Jha, R.P., Shri, N., Patel, P. et al. Trends in the diabetes incidence and mortality in India from 1990 to 2019: a joinpoint and age-period-cohort analysis. J Diabetes Metab Disord 20, 1725–1740 (2021). https://doi.org/10.1007/s40200-021-00834-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-021-00834-y